Reduction of Adipogenesis and Lipid Accumulation by <i>Taraxacum officinale</i> (Dandelion) Extracts in 3T3L1 Adipocytes: An <i>in vitro</i> Study

Marta González-Castejón, Belén García-Carrasco, Raquel Fernandez‐Dacosta, Alberto Dávalos, Arantxa Rodríguez‐Casado

Phytotherapy Research · 2013 · 43 citations · 24 references

Concepts

Abstract

In this in vitro study, we have investigated the ability of Taraxacum officinale (dandelion) to inhibit adipocyte differentiation and lipogenesis in 3T3-L1 preadipocytes. HPLC analysis of the three plant extracts used in this study-leaf and root extracts and a commercial root powder-identified caffeic and chlorogenic acids as the main phenolic constituents. Oil Red O staining and triglyceride levels analysis showed decreased lipid and triglyceride accumulation, respectively. Cytotoxicity was assessed with the MTT assay showing non-toxic effect among the concentrations tested. DNA microarray analysis showed that the extracts regulated the expression of a number of genes and long non-coding RNAs that play a major role in the control of adipogenesis. Taken together, our results indicate that the dandelion extracts used in this study may play a significant role during adipogenesis and lipid metabolism, and thus, supporting their therapeutic interest as potential candidates for the treatment of obesity.

References

24